The regulatory mechanisms linking ferroptosis and the tumor immune microenvironment are highlighted, a critical discussion of recent developments in bionanomaterial‐based therapeutic platforms is provided, and the challenges and prospects for clinical application of these platforms for immunotherapy are outlined.
Abstract
Ferroptosis, an iron‐dependent form of regulated cell death, is frequently dysregulated in both tumor and immune cells, contributing to tumor progression and limiting the effectiveness of cancer immunotherapy. Defining the molecular mechanisms that govern ferroptosis and its effects within the tumor immune microenvironment is critical for understanding its dual role in cancer biology. While modulation of ferroptosis presents a promising therapeutic strategy, non‐specific targeting may also impair normal tissues and tumor‐infiltrating immune cells. In this context, nanoparticle‐based delivery systems offer a potential approach to selectively regulate ferroptosis within tumors. Such strategies may enable precise remodeling of the tumor microenvironment and enhance antitumor immune responses, thereby improving immunotherapy outcomes. This review highlights the regulatory mechanisms linking ferroptosis and the tumor immune microenvironment, provides a critical discussion of recent developments in bionanomaterial‐based therapeutic platforms, and outlines the challenges and prospects for clinical application of these platforms for immunotherapy.
Immunotherapy has transformed cancer treatment, yet its efficacy in solid tumors remains constrained by primary or acquired resistance. Increasing evidence suggests that ferroptosis sensitivity is shaped not only by tumor intrinsic metabolic programs but also by the surrounding microenvironment. Ferroptosis, an iron-de...
Wan-Qiu Zhang, Xiao-Fei Zhang, Si-Lin Kong et al.· Cellular Reprogramming· 0 citations
The biological rationale for ferroptosis-targeted cancer therapy is summarized, major translational barriers are analyzed, and nanomedicine strategies that may move ferroptosis induction from experimental proof of concept toward clinically interpretable intervention are synthesized.
Yan-Pin Ma, Zi-Yi Xu, Huda Akram et al.· Frontiers in Molecular Biosc...· 0 citations
This review summarizes the molecular mechanisms underlining the relationship between ferroptosis and cancer biology, tumor progression, tumor microenvironment, and therapy resistance, with particular interest in its emerging relevance and therapeutic potential in pediatric oncology, while critically considering the cur...
A. Di Paola, M. Marrapodi, Giuseppe Di Feo et al.· International Journal of Mol...· 0 citations
This review summarizes recent progress in the molecular mechanisms of pyroptosis and highlights emerging nanomedicine strategies designed to precisely induce pyroptosis within tumors to inspire next‐generation immunotherapeutic interventions against cancer.
Pengfei Wang, Xinxin Sun, Yuning Yang et al.· Advanced Healthcare Material...· 0 citations
Ferroptosis is an iron-dependent form of regulated cell death, which is manifested by the lethal accumulation of lipid peroxides. While it is considered a promising strategy for the elimination of apoptosis-resistant cancer cells, growing evidence highlights the dual role of ferroptosis within the tumor microenvi...
A. Jurga, Natalia Leśniowska, Olga Malik et al.· Cell Communication and Signa...· 0 citations
This review systematically integrates the latest insights into the molecular mechanisms regulating ferroptosis, the pathophysiology of various intestinal diseases, and translational therapeutic strategies to provide a comprehensive roadmap for leveraging ferroptosis to manage intestinal diseases.
Liyan Deng, Kangdi Liu, Jia-Li Peng et al.· Medicinal research reviews (...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.